Pharmacometrics Africa is pleased to announce the addition of two distinguished experts, Amita Joshi and Samer Mouksassi, to our Scientific Advisory Board. Their extensive experience and contributions to the field of pharmacometrics and clinical pharmacology bring invaluable insights to our organisation.
Amita Joshi, PhD
Amita Joshi serves as the Vice President of Clinical Pharmacology at Genentech/Roche. With over 25 years of experience in drug development, Amita leads a team dedicated to determining optimal dosing regimens for medicines. She has been a key figure in capacity building for clinical pharmacology and pharmacometrics, initiating numerous fellowship and training programs, including partnerships with esteemed institutions like UCSF, Howard University, and the Africa Research Excellence Fund (AREF). Her work in establishing the AREF-Roche and Genentech Fellowship Program exemplifies her commitment to strengthening African scientific infrastructure. Dr. Joshi is also an Adjunct Professor at UCSF, contributing to a new curriculum in AI and Computational Drug Discovery and Development, and serves as an Associate Editor for Clinical Pharmacology and Therapeutics.
Samer Mouksassi
Samer Mouksassi, Senior Director – Africa region Lead at Certara, is well regarded for his efforts in developing pharmacometrics teams in Cairo, Egypt, and Cape Town, South Africa. His work focuses on creating a sustainable ecosystem for pharmacometrics in Africa, emphasizing the use of modeling and simulation to enhance drug development decisions. He is also known for his contribution and extensive use of tools that bridge the gap between non-coders and complex data analysis, such as cofeffectsplot, ggquickeda, and tidyvpc. His mentorship in the Applied Pharmacometrics Training program further showcases his dedication to nurturing future leaders in the field.
Pharmacometrics Africa is excited to benefit from the expertise of Amita and Samer as we continue to advance pharmacometrics and clinical pharmacology in Africa. Their contributions will undoubtedly enhance our mission to foster a robust scientific community on the continent.